MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer
PRIVATENov 03, 2026
New to company · from Novo Nordisk“Neil joins from Novo Nordisk and brings more than 20 years of experience in business development and strategic transactions”
Position
Chief Business Officer
Company
MitoRx Therapeutics
Neil Anderson, PhD
OxfordBiotechnologyHealth CareTherapeutics
Description
MitoRx Therapeutics announces the appointment of Neil Anderson, PhD as Chief Business Officer, effective immediately. He joins the senior management team to enhance the company's business development capabilities as they advance MTRX31 towards clinical stages.
Who to call at MitoRx Therapeutics, and when
A new leader at MitoRx Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day MitoRx Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at MitoRx Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MitoRx Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
MitoRx Therapeutics
Location
Oxford, England, United Kingdom
About
MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MitoRx Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
OxfordBiotechnologyHealth CareTherapeutics